Fig. 2. Change in the average monthly medical and pharmaceutical expenditure for lung cancer (Total, per patient)
^*unit: costs/patients per 100,000 population, 10 thousand won
^†Dotted line indicates the time of introduction of immunotherapy.
^‡Marked with ‘-‘ before the introduction of reimbursements.
^§Duplicates being across the drug classes and had not being removed.
Abbreviation: CAGR, Compound Annual Growth Rate

Yakhak Hoeji 2023;67:224-30 https://doi.org/10.17480/psk.2023.67.4.224

© 2023 Yakhak Hoeji